Vimarsana
Biggest News Aggregation in the World

Page 2 - Diffusion Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diffusion Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diffusion Pharmaceutical Today - Breaking & Trending Today

Diffusion Pharmaceuticals : EIP Pharma to Present at JMP Securities Life Sciences Conference - Form 8-K - Vimarsana News

Diffusion Pharmaceuticals : EIP Pharma to Present at JMP Securities Life Sciences Conference - Form 8-K

EIP Pharma to Present at JMP Securities Life Sciences Conference BOSTON, MA - May 11, 2023 - EIP Pharma Inc., a clinical stage company focused on developing treatments for... | May 11, 2023

Analyzing Diffusion Pharmaceuticals (NASDAQ:DFFN) & Cyclerion Therapeutics (NASDAQ:CYCN) - Vimarsana News

Analyzing Diffusion Pharmaceuticals (NASDAQ:DFFN) & Cyclerion Therapeutics (NASDAQ:CYCN)

Cyclerion Therapeutics (NASDAQ:CYCN – Get Rating) and Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation. Risk & Volatility Cyclerion Therapeutics has a beta of […]

-$0.04 Earnings Per Share Expected for Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) This Quarter - Vimarsana News

-$0.04 Earnings Per Share Expected for Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) This Quarter

Brokerages expect that Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) will post ($0.04) earnings per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Diffusion Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.03) and the lowest estimate coming in at ($0.04). Diffusion Pharmaceuticals posted earnings of […]

Zacks Investment Research Comments on Diffusion Pharmaceuticals Inc.'s FY2022 Earnings (NASDAQ:DFFN) - Vimarsana News

Zacks Investment Research Comments on Diffusion Pharmaceuticals Inc.'s FY2022 Earnings (NASDAQ:DFFN)

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) – Zacks Investment Research cut their FY2022 earnings per share estimates for Diffusion Pharmaceuticals in a report issued on Wednesday, March 23rd. Zacks Investment Research analyst D. Bautz now forecasts that the company will post earnings of ($0.17) per share for the year, down from their prior forecast […]

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference - Vimarsana News

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference

Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference CHARLOTTESVILLE, Va., Jan. 11, 2021 — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021. Conference specifics are as follows: Event: Date:  The recorded presentation can be accessed by conference participants and the presentation deck can be ...